Lanreotide Acetate

CAS: 127984-74-1

Ref. TR-L174600

Informação sobre produto

• Nome: Lanreotide Acetate
• Sinónimos: 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv., BIM 23014C, Somatulina, Somatuline,L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide, acetate (salt) (9CI), 10-(4-Aminobutyl)-19-[(2-Amino-3-Naphthalen-2-Yl-Propanoyl)Amino]-N-(1-Carbamoyl-2-Hydroxy-Propyl)-16-[(4-Hydroxyphenyl)Methyl]-13-(1H-Indol-3-Ylmethyl)-6,9,12,15,18-Pentaoxo-7-Propan-2-Yl-1,2-Dithia-5,8,11,14,17-Pentazacycloicosane-4-Carboxamide

Descrição

Applications Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma.
References Kuehnen, P. et al.: Horm. Res. Paediat., 78, 106 (2012); Li, Z. et al.: J. Int. Med. Res., 40, 517 (2012);

• Marca: TRC

Propriedades químicas

• Peso molecular: 1156.38
• Fórmula: C₅₄H₆₉N₁₁O₁₀S₂·C₂H₄O₂
• Cor/forma: Neat
• InChI: InChI=1S/C54H69N11O10S2.C2H4O2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55;1-2(3)4/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74);1H3,(H,3,4)/t30-,38-,40+,41+,42-,43+,44+,45+,46+;/m1./s1